Management of Continuous Glucose Monitors in Radiation Oncology Patients.
Where this comes from
- Record sourced from PubMed, PMID 39142390.
- Also identified by DOI 10.1016/j.prro.2024.06.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Continuous glucose monitors (CGMs) are an increasingly prevalent electronic medical device used by patients with diabetes, offering several advantages over "finger sticks." There is a resulting rise in patients with CGMs seen in radiation oncology clinics. Manufacturers specify that CGMs should not be exposed to radiation (both diagnostic and therapeutic) due to the risk of device damage, creating challenges for patients and providers. We present a workflow for the management of CGMs in radiation oncology patients, beginning with systematic screening by providers and staff. We propose options for CGM management together with the device prescriber, including removal of the CGM or keeping it in place with periodic finger sticks to confirm the accuracy and offer guidance to radiation oncology providers and staff.
Medical subject headings
- Blood Glucose Self-Monitoring
- Radiation Oncology
- Blood Glucose
- Neoplasms